Medicare Enrolled
Dr. William Smolinski, D.O.
Cardiovascular Disease · Allentown, PA
Practice pattern: Electrophysiology & Remote
— Practice combining electrophysiology and remote services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Smolinski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Smolinski?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Smolinski
Dr. William Smolinski is a cardiovascular disease specialist in Allentown, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Smolinski performed 5,021 Medicare services across 2,544 unique beneficiaries.
Between the years covered by Open Payments, Dr. Smolinski received a total of $13,853 from 37 pharmaceutical and/or device companies across 944 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Smolinski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 8% volume in PA
$13,853 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,021
Medicare services
Top 8% in PA for cardiovascular disease
2,544
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~264 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,386 | $86 | $229 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,334 | $10 | $35 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
425 | $9 | $25 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
298 | $4 | $15 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
273 | $15 | $55 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
222 | $143 | $380 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
213 | $21 | $80 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
186 | $91 | $230 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
112 | $138 | $320 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
87 | $9 | $100 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
87 | $18 | $80 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
87 | $25 | $75 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
78 | $19 | $60 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
63 | $26 | $100 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
41 | $102 | $350 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
39 | $56 | $120 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
28 | $128 | $400 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
24 | $167 | $400 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
14 | $52 | $100 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
13 | $50 | $250 |
| Evaluation of implantable heart and blood vessel monitoring system This procedure involves checking the function and data of an implanted device used to monitor heart and blood vessel activity. |
11 | $35 | $80 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
16.4% high complexity
1.3% medium
82.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,853
Total received (2018-2024)
Avg $1,979/year across 7 years
Top 18% in PA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
944
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,853 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,116
2023
$2,090
2022
$2,115
2021
$1,655
2020
$1,568
2019
$2,020
2018
$2,290
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$513
PFIZER INC.
$378
Novartis Pharmaceuticals Corporation
$189
Amgen Inc.
$189
Boehringer Ingelheim Pharmaceuticals, Inc.
$168
Esperion Therapeutics, Inc.
$124
Merck Sharp & Dohme LLC
$118
Novo Nordisk Inc
$94
E.R. Squibb & Sons, L.L.C.
$77
Lilly USA, LLC
$47
Lexicon Pharmaceuticals, Inc.
$43
Daiichi Sankyo Inc.
$42
Kiniksa Pharmaceuticals International, plc
$41
AstraZeneca Pharmaceuticals LP
$31
Janssen Pharmaceuticals, Inc
$25
Abbott Laboratories
$23
Bayer Healthcare Pharmaceuticals Inc.
$13
Top 3 companies account for 51.1% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$1,736
Boston Scientific Corporation
$1,644
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,413
Novartis Pharmaceuticals Corporation
$1,278
Janssen Pharmaceuticals, Inc
$1,076
AstraZeneca Pharmaceuticals LP
$873
BOSTON SCIENTIFIC CORPORATION
$761
E.R. Squibb & Sons, L.L.C.
$697
Amgen Inc.
$669
Amarin Pharma Inc.
$644
Esperion Therapeutics, Inc.
$450
SANOFI-AVENTIS U.S. LLC
$449
Kowa Pharmaceuticals America, Inc.
$413
Merck Sharp & Dohme LLC
$404
Novo Nordisk Inc
$167
Abbott Laboratories
$148
Bayer HealthCare Pharmaceuticals Inc.
$120
Gilead Sciences, Inc.
$114
Regeneron Healthcare Solutions, Inc.
$111
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$83
Daiichi Sankyo Inc.
$72
Merck Sharp & Dohme Corporation
$71
Lexicon Pharmaceuticals, Inc.
$67
Lilly USA, LLC
$47
Relypsa, Inc.
$46
Lundbeck LLC
$44
ARALEZ PHARMACEUTICALS US INC.
$42
Kiniksa Pharmaceuticals International, plc
$41
Bayer Healthcare Pharmaceuticals Inc.
$31
Edwards Lifesciences Corporation
$30
Baxter Healthcare
$20
Astellas Pharma US Inc
$20
Actelion Pharmaceuticals US, Inc.
$20
Bardy Diagnostics, Inc.
$15
BIOTRONIK INC.
$15
ABBVIE INC.
$12
Medtronic Vascular, Inc.
$11
Top 3 companies account for 34.6% of all-time payments
Associated products mentioned in payments ›
Arcalyst · BRILINTA · CAMZYOS · CHANTIX · CREON · Carnation Ambulatory Monitor · Confirm Rx · Corlanor · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · GENERAL THERAPIES · GENERAL - TACHY · GENERAL - THERAPIES · GENERAL TACHY · GENERAL THERAPIES · HeartMate · Hillrom - Carnation Ambulatory Monitor · INCEPTA · INJECTAFER · Inpefa · JARDIANCE · Kerendia · LATITUDE · LEQVIO · LEXISCAN · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MULTAQ · NEXLETOL · NEXLIZET · NORTHERA · OPSUMIT · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · RESONATE · Repatha · Reveal LINQ · Rybelsus · SQ-RX PULSE GENERATOR · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · VERQUVO · VIGILANT · VYNDAQEL · Vascepa · Veltassa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZEPBOUND · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
131
Per 100K population
34.9
County median income
$77,493
Nearest hospital
LEHIGH VALLEY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Smolinski is an electrophysiology & remote specialist, with above-average Medicare volume (top 8% in PA), with low-engagement industry engagement in the top 18% of PA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Smolinski experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Smolinski performed 1,386 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Smolinski receive payments from pharmaceutical companies?
Yes. Dr. Smolinski received a total of $13,853 from 37 companies across 944 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Smolinski's costs compare to other cardiologists in Allentown?
Dr. Smolinski's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Smolinski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Allentown
Browse cardiologists in Allentown ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in PA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in PA
Which PA cardiologists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology